How Many Clovis Oncology Inc (NASDAQ:CLVS)’s Analysts Are Bearish?

Nektar Therapeutics insiders have sold a net of -215,603 shares during the past three months, which implies that the company’s top executives have been feeling bearish about the stock’s outlook. At the time of writing, Shares the company recently traded 58.96% away 52-week low and noted price movement 0.52% away from the 52-week high level. The Company’s Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases…

October 6, 2017
Read More >>

YouTube Tweaks Its Search Results After Rise of Las Vegas Conspiracy Theories

October 5, 2017

Although the change to the search algorithm was already in the works, YouTube made a decision to roll it out sooner in response to criticism of the way it handled results when users searched for “Las Vegas Shooting“. That’s because dozens of conspiracy theory videos-including one from Alex Jones, viewed more than 1 million times-are being promoted by YouTube in the wake of the mass shooting. When they searched for…

Read More >>